(Q43948614)

28 November 2017

Sindbis virus vectors elicit hemagglutinin-specific humoral and cellular immune responses and offer a dose-sparing strategy for vaccination (English)

1 reference

28 November 2017

0 references

0 references

3

1 reference

28 November 2017

5

1 reference

28 November 2017

Stephen J Turner

7

0 references

Rob J Center

2

object named as

Rob J Center

1 reference

28 November 2017

Annett Miller

1

1 reference

28 November 2017

Georgia Deliyannis

4

1 reference

28 November 2017

Jane L Howard

6

1 reference

28 November 2017

Damian F J Purcell

8

1 reference

28 November 2017

language of work or name

English

0 references

publication date

28 August 2008

1 reference

28 November 2017

8

1 reference

inferred from page(s)

published in

Vaccine

1 reference

28 November 2017

26

1 reference

28 November 2017

44

1 reference

28 November 2017

5641-5648

1 reference

Vaccine manufacturing: challenges and solutions

28 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Antibody response to influenza vaccination in the elderly: a quantitative review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Cell-mediated protection in influenza infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Th cell-deficient mice control influenza virus infection more effectively than Th- and B cell-deficient mice: evidence for a Th-independent contribution by B cells to virus clearance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Biological properties of an influenza A virus-specific killer T cell clone. Inhibition of virus replication in vivo and induction of delayed-type hypersensitivity reactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Layered amplification of gene expression with a DNA gene delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

A plasmid-based self-amplifying Sindbis virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Comparison of the protective efficacy of naked DNA, DNA-based Sindbis replicon, and packaged Sindbis replicon vectors expressing Hantavirus structural genes in hamsters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Infectious Sindbis virus transient expression vectors for studying antigen processing and presentation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. I. Significant variation in repertoire expression between individual mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Involvement of the mannose receptor in infection of macrophages by influenza virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Antigenic determinants of influenza virus hemagglutinin. XII. the epitopes of a synthetic peptide representing the C-terminus of HA1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

IgG subclass response and protection against challenge following immunisation of mice with various influenza A vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Recognition of disparate HA and NS1 peptides by an H-2Kd-restricted, influenza specific CTL clone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Lipid-containing mimetics of natural triggers of innate immunity as CTL-inducing influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Comparative analysis of humoral immune responses to HIV type 1 envelope glycoproteins in mice immunized with a DNA vaccine, recombinant Semliki Forest virus RNA, or recombinant Semliki Forest virus particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

7 January 2021

Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

Sindbis virus DNA-based expression vectors: utility for in vitro and in vivo gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

7 January 2021

DNA immunization against herpes simplex virus: enhanced efficacy using a Sindbis virus-based vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

7 January 2021

Recombinant Sindbis viruses expressing a cytotoxic T-lymphocyte epitope of a malaria parasite or of influenza virus elicit protection against the corresponding pathogen in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

7 January 2021

Relative immunogenicity of the cold-adapted influenza virus A/Ann Arbor/6/60 (A/AA/6/60-ca), recombinants of A/AA/6/60-ca, and parental strains with similar surface antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

7 January 2021

Definition of amino acid residues on the epitope responsible for recognition by influenza A virus H1-specific, H2-specific, and H1- and H2-cross-reactive murine cytotoxic T-lymphocyte clones.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.102

7 January 2021

10.1016/J.VACCINE.2008.07.102

Identifiers

DOI

1 reference

28 November 2017

1 reference